Agenus | AGEN - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Celldex Therapeutics USD -83.58M 2.76M 2026-03
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 10.29B 1.86B 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 8.27B 1.08B 2026-03
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck EUR 1.6B 69M 2026-06
Merck USD -1.54B 7.84B 2026-03
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.01B 18M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 43.96M 1.16M 2026-06